REGENERON PHARMACEUTICALS INC PATENTS FACING OPPOSITIONS
Top patents of REGENERON PHARMACEUTICALS INC facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3716992B1 | 10 Aug, 2022 | Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders | Nov, 2038 | 4 | |
| EP2944306B1 | 27 Jan, 2021 | Vegf Antagonist Formulations Suitable For Intravitreal Administration | Jun, 2027 | 3 | |
| EP3645553B1 | 15 Mar, 2023 | Tropism-Modified Recombinant Viral Particles And Uses Thereof For The Targeted Introduction Of Genetic Material Into Human Cells | Jun, 2038 | 2 |